The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
Harry Yoon, MD
Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH
Vallerie V. McLaughlin, MD
Thomas Cascino, MD
Bradley A. Maron, MD
Effective Monitoring and Management of Adverse Effects in Metastatic ESCC
Jaffer Ajani, MD
Updates From the 7th World Symposium Task Force
Eric D. Austin, MD, MSCI
Hilary M. DuBrock, MD
H. James Ford, MD
Gustavo A. Heresi, MD, MS
Gergely Meszaros, JD, MSc
Oksana A. Shlobin, MD
Ioana Preston, MD
Lucilla Piccari, MD, PhD
Biomarkers of the Storm: Decoding IRI’s Signature
Manesh R. Patel, MD
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
The Heart’s Aftermath: IRI’s Impact on Cardiac Morbidity & Mortality
Unveiling the Reperfusion Paradox
What’s on the Horizon for IRI Management?
Reperfusion Paradox: The Hidden Threat in STEMI After PCI and the Quest for Effective Therapeutics
PAD Stage, Risk Assessment & Comorbidities
Connie N. Hess, MD, MHS
Latest Guidance on Exercise Therapy & Lifestyle Modification – Treating Functional Limitations
Naomi Hamburg, MD, MS
Medical Therapy: New Horizons of Diabetic Therapies
Medical Therapy: Antithrombotic Management of PAD—What Has Changed?
Marc P. Bonaca, MD, MPH
Revascularization Therapy: Who, How & When?
Alik Farber, MD, MBA, FACS, DFSVS
Medical Therapy: Lipid Modifying Therapies
Schuyler Jones, MD
Overcoming Disparities of Care - Impact of Social Determinants of Health of PAD
Loading...
We're glad to see you're enjoying MedEd On The Go… but how about a more personalized experience?
Press cancel to remain on MedEd On The Go. Press the link below or the continue button to keep going.